Styrylpyrones from the medicinal fungus Phellinus baumii and their antioxidant properties

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 18, 2010, Pages 5459-5461

  Lee, In Kyoung ^a   Han, Myung Suk ^a   Lee, Myeong Seok ^a   Kim, Young Sook ^a   Yun, Bong Sik ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Antioxidant; Fenton reaction; Iron chelator; Phellinus baumii; Styrylpyrones

Indexed keywords

ANTIOXIDANT; BAUMIN; DAVALLIALACTONE; HISPIDIN; HYPHOLOMINE B; INOSCAVIN A; INTERFUNGIN A; PHELLIGRIDIN D; PYRONE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG ISOLATION; DRUG STRUCTURE; FENTON REACTION; FUNGUS; HETERONUCLEAR MULTIPLE BOND CORRELATION; INONOTUS XERANTICUS; IRON CHELATION; NONHUMAN; PHELLINUS BAUMII; PHELLINUS IGNARIUS; PHELLINUS LINTEUS; PROTON NUCLEAR MAGNETIC RESONANCE;

ANTIOXIDANTS; BASIDIOMYCOTA; DNA; DNA BREAKS, SINGLE-STRANDED; IRON; IRON CHELATING AGENTS; PYRONES;

BASIDIOMYCOTA; FUNGI; INONOTUS BAUMII; INONOTUS LINTEUS; INONOTUS XERANTICUS; PHELLINUS;

EID: 77956177943     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2010.07.093     Document Type: Article

References (21)

1. Y.-M. Park, J.-H. Won, Y.-H. Kim, J.-W. Choi, H.-J. Park, and K.-T. Lee J. Ethnopharmacol. 101 2005 120
2. J. Guo, T. Zhu, L. Collins, Z.-X.J. Xiao, S.-H. Kim, and C.-Y. Chen Mol. Carcinog. 46 2007 144
3. S.V. Reshetnikov, S.P. Wasser, and K.K. Tan Int. J. Med. Mushrooms 3 2001 361
4. I.K. Lee, and B.S. Yun Bioorg. Med. Chem. Lett. 16 2006 2376
5. I.K. Lee, and B.S. Yun Bioorg. Med. Chem. 15 2007 3309
6. I.K. Lee, Y.S. Kim, Y.W. Jang, J.Y. Jung, and B.S. Yun Bioorg. Med. Chem. Lett. 17 2007 6678
7. J.Y. Jung, I.K. Lee, S.J. Seok, H.J. Lee, Y.H. Kim, and B.S. Yun J. Appl. Microbiol. 104 2008 1824
8. S.D. Kim, I.K. Lee, W.M. Lee, J.Y. Cho, H.J. Park, J.W. Oh, S.C. Park, S.K. Kim, Y.S. Kwak, B.S. Yun, and M.H. Rhee Eur. J. Pharmacol. 584 2008 361
9. Y.G. Lee, W.M. Lee, J.Y. Kim, J.Y. Lee, I.K. Lee, B.S. Yun, M.H. Rhee, and J.Y. Cho Br. J. Pharmacol. 154 2008 852
10. T. Kamei, G. Hoshino, K. Murata, and Y. Torium Focus Altern. Complement. Ther. 8 2003 505
11. J.S. Bae, M.H. Hwang, K.H. Jang, M.H. Rhee, K.W. Lee, W.S. Jo, S.K. Choi, H.I. Yun, J.H. Lim, J.C. Kim, and S.C. Park J. Toxicol. Public Health 20 2004 37
12. M.Y. Shon, T.H. Kim, and N.J. Sung Food Chem. 82 2003 593
13. T.Y. Shin, H.Y. Shin, S.H. Kim, D.K. Kim, B.S. Chae, C.H. Oh, M.G. Cho, S.H. Oh, J.H. Kim, T.K. Lee, J.S. Park, and S.Y. Kim Nat. Prod. Sci. 12 2006 232
14. 2O. The ethyl acetate-soluble fraction was subjected to a column of Sephadex LH-20 eluted with MeOH to give three fractions (Fr-1, Fr-2, and Fr-3), which were divided by monitoring with HPLC (LaChrom Elite HPLC, Hitachi Co., Tokyo, Japan). HPLC conditions were as follows: column, TSK gel ODS-100 V (4.6 × 150 mm, Tosoh Co., Tokyo, Japan); solvent, a gradient with an increasing amount of MeOH (10 → 90%) in water/0.04% trifluoroacetic acid (TFA); flow rate, 1.0 mL/min; detector, photodiode array detector. Compounds 1-5 were purified from Fr-1 as follows; Fr-1 was separated by solid phase extraction by eluting with 50-60% aqueous MeOH to provide two fractions. One fraction was concentrated under reduced pressure to provide compound 4 (60 mg). The other fraction was separated on a column of Sephadex LH-20 with 70% aqueous MeOH to afford three fractions, Fr-1-1, Fr-1-2, and Fr-1-3. The Fr-1-1 fraction was purified by preparative reversed-phase HPLC on a column (Cosmosil RP-18, 20 × 150 mm) and eluted with 40% aqueous MeOH containing 0.04% TFA to give compounds 1 (8 mg) and 2 (20 mg). Fr-1-2 and Fr-1-3 fractions were purified, respectively, by reversed-phase TLC with 60% aqueous MeOH to provide 3 (13 mg) and 5 (7 mg), respectively. Fraction Fr-2 was separated by solid phase extraction, eluting with 50-60% aqueous MeOH, followed by Sephadex LH-20 column chromatography, and eluted with 70% aqueous MeOH to give compound 6 (4 mg). Compound 7 (8 mg) was purified from Fr-3 using Sep-pak ODS cartridge, and eluted with 50-60% aqueous MeOH.
15. 11, 523.1241).
16. C.B. Cui, Y. Tezuka, H. Yamashita, T. Kikuchi, H. Nakano, T. Tamaoki, and J.H. Park Chem. Pharm. Bull. 40 1992 1711
17. J.P. Kim, B.S. Yun, Y.K. Shim, and I.D. Yoo Tetrahedron Lett. 40 1999 6643
18. I.K. Lee, J.Y. Jung, S.J. Seok, W.G. Kim, and B.S. Yun Bioorg. Med. Chem. Lett. 16 2006 5621
19. I.K. Lee, Y.W. Jang, S.H. Yu, and B.S. Yun Bioorg. Med. Chem. Lett. 17 2007 4906
20. J.K. Donnely, and D.S. Robinson Free Rad. Res. 22 1994 147
21. B. Schwyn, and J.B. Neilands Anal. Biochem. 160 1987 47